Funded Startups in Geneva
Geneva rounds in this listing span from Chord Therapeutics on 2020-10-13 ($16M) to VM Agritech on 2025-11-28 ($18M).
Geneva rounds in this listing span from Chord Therapeutics on 2020-10-13 ($16M) to VM Agritech on 2025-11-28 ($18M). The largest disclosed amount is Gavi, the Vaccine Alliance at $1.0B (2022-05-16), which dwarfs every other disclosed round here—next-highest disclosed figures include SonarSource at $412M (2022-04-26) and BGN at $233M (2025-02-19). Most other disclosures cluster far lower: only a handful exceed $100M (e.g., Taurus $65M is below that mark, while EBAMed is $2M on 2025-01-21). Several sector and stage concentrations also show up: Energy appears 3 times (Sparta $42M on 2025-02-24; BGN $233M on 2025-02-19; Transmutex SA $4M on 2025-01-22), and “Series Unknown” appears in 26 of 48 rows while “undisclosed” amounts appear in 8 of 48 rows. Geographic labeling is overwhelmingly Geneva, Geneve, Switzerland, with a smaller set explicitly listing Geneva, United States or Geneva, New York, United States.
Most recent rounds
48 shownRelated listings
Frequently asked
What’s the largest disclosed round in the Geneva list, and how far above the rest is it?
Gavi, the Vaccine Alliance’s $1.0B debt financing on 2022-05-16 is an outlier: the next-largest disclosed amounts are $412M (SonarSource on 2022-04-26) and $233M (BGN on 2025-02-19), with most other rounds well below $100M.
Are there dense date clusters among the most recent rounds shown?
Yes. Multiple rounds land in a tight window in early 2025: EBAMed $2M (2025-01-21), Transmutex SA $4M (2025-01-22), BGN $233M (2025-02-19), and Sparta $42M (2025-02-24), followed by Clee Medical $170K (2025-03-21). There’s also a notable cluster in Feb 2024 with GeNeuro $5M (2024-02-01) and Emerald Stay $15M (2024-02-01).
Which stage labels dominate, and how does “undisclosed” affect comparability?
“Series Unknown” is the most frequent classification, appearing in 26 of 48 rows (e.g., BGN 2025-02-19 for $233M, WISeKey 2024-10-23 for $30M). “undisclosed” amounts occur in 8 of 48 rows (e.g., GliaPharm on 2024-09-17 and Backbone on 2024-08-15), so size-based comparisons must rely only on disclosed dollar amounts.
Do any sectors appear often enough to suggest a repeat investing focus?
Energy is one of the clearest repeats with 3 entries: Transmutex SA ($4M on 2025-01-22), BGN ($233M on 2025-02-19), and Sparta ($42M on 2025-02-24). Beyond that, most sectors are represented once or twice in the 48-row view.
Which geographies show up under the Geneva umbrella, and are there same-city inconsistencies?
The labeling is predominantly “Geneva, Geneve, Switzerland” (e.g., BGN on 2025-02-19 for $233M; SonarSource on 2022-04-26 for $412M). A smaller subset is explicitly “Geneva, United States” (e.g., VM Agritech on 2025-11-28 for $18M) and “Geneva, New York, United States” (e.g., RealEats $16M on 2021-10-26).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.